UNSPSC 51412802: Perfomedil

This classification denotes a vasodilating agent with the molecular formula C19H29NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8A8NY1Z12E, chemically known as 4-(3-methyl-1-piperidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone but generally known as perfomedil, which bears US NIH Compound Identifier 65831. European Medicines Agency schedules Perfomedil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09723MIG.

UNSPSC 51412802 Perfomedil is a Commodity code that captures state and local procurement of emergency and critical-care medications, including advanced life support drugs, vasopressors, cardiac agents, and antiarrhythmics supplied to fire rescue departments, health agencies, and hospital systems. State and local buyers under this code include municipal fire departments, state health agencies, county emergency medical services, and cooperative purchasing alliances serving multi-state government networks. Work solicited ranges from firm-priced one-year supply contracts for specific medication line items with expiration and replacement guarantees, to multi-state cooperative purchasing agreements for generic pharmaceuticals and OTC products distributed through authorized wholesalers, to preliminary market-intelligence requests from state health commissions exploring direct-to-manufacturer pharmacy benefit models. Issuing bodies characterize the code's breadth: municipal purchasing departments handling tactical emergency medical supply (the City of Tampa's Purchasing Department), state health agencies conducting strategic pharmacy program redesign (the Texas Health and Human Services Commission), and cooperative purchasing alliances spanning multiple jurisdictions and states (the Minnesota Multistate Cooperative Purchasing Alliance, which includes Oregon).

Recent activity concentrates in Texas, Minnesota, and Florida, with multi-state footprints emerging through cooperative purchasing mechanisms. The City of Tampa issued IFB No. 26P00188 for Advanced Life Support Medications on April 24, 2026, with a due date of April 8, 2026 and an estimated contract value of $40,000, requiring four specific medication line items with nine-month minimum expiration dating and ten-calendar-day delivery performance, and including a 5 percent Small Local Business Enterprise bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 on January 20, 2026 with a March 26, 2026 response deadline, establishing multi-award contracts for generic multi-source pharmaceuticals and OTC products effective July 1, 2026, requiring vendors to supply through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson with pricing weighted 75 percent on competitiveness and compliance with cGMP and Drug Supply Chain Security Act certification. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 as a preliminary market-intelligence request regarding direct-to-manufacturer prescription programs without stated budget or award parameters, signaling potential future competitive solicitation.